Markets › United States › NYSE › NVO

Novo Nordisk AS

NYSE:NVOHealthcare

$38.42−1.06%At closeAt close · Tue 20 Oct · ≈ AED 141.10 · Market cap $172.62B · Next earnings Wed 4 Nov

No breakdown of this kind is reported.

North America63%+50%

EMEA24%+15%

Rest of World13%+11%

Share of FY2023 revenue · growth vs FY2022

Segment / region	Type	Fiscal year	Currency	Revenue (millions)	Share of revenue
North America	Region	2023	DKK	136,629.0	63.4%
EMEA	Region	2023	DKK	50,867.0	23.6%
Rest of World	Region	2023	DKK	28,078.0	13.0%
North America	Region	2022	DKK	91,107.0	56.7%
EMEA	Region	2022	DKK	44,236.0	27.5%
Rest of World	Region	2022	DKK	25,402.0	15.8%
North America	Region	2021	DKK	67,263.0	53.9%
EMEA	Region	2021	DKK	37,706.0	30.2%
Rest of World	Region	2021	DKK	19,812.0	15.9%

Revenue by product and region · reported currencyUpdated 31 Dec 2023 ·

ⓘ

Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.